亚洲社会药学

• 论文 • 上一篇    下一篇

Research on Drug-Patent Linkage System under the New Situation

Huang Yufeng, Luo Suping, Yuan Hongmei*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2019-03-20 发布日期:2019-03-20

Research on Drug-Patent Linkage System under the New Situation

Huang Yufeng, Luo Suping, Yuan Hongmei*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2019-03-20 Published:2019-03-20
  • Contact: Yuan Hongmei, professor. Major research area: pharmaceutical intellectual property rights. Tel: 18341400462, E-mail: yuanhm612@163.com.

摘要: Objective To explore the extent to which the drug-patent linkage system should be implemented in China. Methods The present situation of drug-patent linkage system internationally was analyzed. Then the practices of drug-patent linkage system were discussed through such methods as literature reviews and quantitative scoring methods in combination of selecting the representative countries. Finally the extent to which the drugpatent linkage system should be implemented in China was explored through comparative analysis. Results and Conclusion Compared with the United States, China should establish a drug-patent linkage system that will weaken the protection of original patented drugs and promote the timely marketing of high-quality generic drugs and appropriately prevent the patent abuse.

关键词: drug-patent linkage system, original patented drug, generic drug, patent abuse

Abstract: Objective To explore the extent to which the drug-patent linkage system should be implemented in China. Methods The present situation of drug-patent linkage system internationally was analyzed. Then the practices of drug-patent linkage system were discussed through such methods as literature reviews and quantitative scoring methods in combination of selecting the representative countries. Finally the extent to which the drugpatent linkage system should be implemented in China was explored through comparative analysis. Results and Conclusion Compared with the United States, China should establish a drug-patent linkage system that will weaken the protection of original patented drugs and promote the timely marketing of high-quality generic drugs and appropriately prevent the patent abuse.

Key words: drug-patent linkage system, original patented drug, generic drug, patent abuse